Boill Healthcare Holdings Limited
HKEX:1246.HK
0.021 (HKD) • At close July 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q2 | 2012 Q4 | 2012 Q3 | 2012 Q2 | 2012 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 10.545 | 274.659 | 76.623 | 271.648 | 173.886 | 842.276 | 197.074 | 19.636 | 41.203 | 65.149 | 282.238 | 137.524 | 0 | 152.102 | 0 | 180.169 | 304.762 | 227.432 | 264.453 | 293.697 | 272.75 | 214.156 | 180.731 | 90.366 | 87.685 | 87.685 |
| Cost of Revenue
| 12.139 | 262.545 | 86.314 | 261.847 | 145.029 | 762.711 | 173.774 | 23.965 | 28.247 | 67.316 | 304.574 | 125.634 | 0 | 156.436 | 0 | 175.705 | 292.123 | 188.281 | 185.565 | 222.806 | 205.007 | 148.502 | 130.313 | 65.156 | 59.257 | 59.257 |
| Gross Profit
| -1.594 | 12.114 | -9.691 | 9.801 | 28.857 | 79.565 | 23.3 | -4.329 | 12.956 | -2.167 | -22.336 | 11.89 | 0 | -4.334 | 0 | 4.464 | 12.639 | 39.151 | 78.888 | 70.891 | 67.743 | 65.654 | 50.418 | 25.209 | 28.428 | 28.428 |
| Gross Profit Ratio
| -0.151 | 0.044 | -0.126 | 0.036 | 0.166 | 0.094 | 0.118 | -0.22 | 0.314 | -0.033 | -0.079 | 0.086 | 0 | -0.028 | 0 | 0.025 | 0.041 | 0.172 | 0.298 | 0.241 | 0.248 | 0.307 | 0.279 | 0.279 | 0.324 | 0.324 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 17.841 | 22.73 | 0 | 14.871 | 0 | 30.402 | 36.937 | 30.937 | 30.279 | 19.633 | 30.907 | 49.099 | 0 | 58.513 | 0 | 52.501 | 51.346 | 33.493 | 37.97 | 22.219 | 28.017 | 19.276 | 14.172 | 7.086 | 7.256 | 7.256 |
| Selling & Marketing Expenses
| 4.548 | 2.423 | 0 | 2.396 | 0 | 9.854 | 11.51 | 4.183 | 2.892 | 4.176 | 6.123 | 6.595 | 0 | 7.613 | 0 | 4.047 | 2.251 | 0 | 0.966 | 0 | 0 | 0 | -3.77 | -3.77 | 0 | 0 |
| SG&A
| 22.389 | 25.047 | 1.676 | 25.941 | 35.393 | 35.087 | 43.209 | 28.238 | 32.088 | 18.002 | 37.03 | 55.694 | 0 | 66.126 | 0 | 56.548 | 53.597 | 33.493 | 38.936 | 22.219 | 28.017 | 19.276 | 6.632 | 3.316 | 7.256 | 7.256 |
| Other Expenses
| 0 | 0 | -159.082 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 22.389 | 25.047 | 160.758 | 25.941 | 35.393 | 35.087 | 43.209 | 28.238 | 32.088 | 18.002 | 76.68 | 60.982 | 0 | 0.158 | 0 | 146.167 | 66.229 | 115.895 | 22.165 | 19.9 | 22.949 | 19.272 | 17.26 | 8.63 | 7.124 | 7.124 |
| Operating Income
| -23.983 | -12.933 | -170.449 | -16.14 | -6.536 | 44.478 | -19.909 | -32.567 | -19.132 | -20.169 | -59.366 | -43.804 | 0 | -70.46 | 0 | -52.084 | -40.958 | 5.658 | 37.656 | 50.968 | 39.944 | 46.382 | 36.48 | 18.24 | 21.172 | 21.172 |
| Operating Income Ratio
| -2.274 | -0.047 | -2.225 | -0.059 | -0.038 | 0.053 | -0.101 | -1.659 | -0.464 | -0.31 | -0.21 | -0.319 | 0 | -0.463 | 0 | -0.289 | -0.134 | 0.025 | 0.142 | 0.174 | 0.146 | 0.217 | 0.202 | 0.202 | 0.241 | 0.241 |
| Total Other Income Expenses Net
| -232.971 | -5.615 | 69.386 | -107.433 | -700.31 | -64.692 | -77.494 | -49.719 | -164.491 | 4.472 | -76.886 | -45.797 | 0 | 13.901 | 0 | -165.615 | -79.134 | -85.747 | 18.376 | -0.304 | 4.368 | -0.671 | -3.505 | -1.753 | 0.032 | 0.032 |
| Income Before Tax
| -256.954 | -18.548 | -101.063 | -123.573 | -706.846 | -20.214 | -97.403 | -82.286 | -183.623 | -15.697 | -136.252 | -89.601 | 0 | -56.559 | 0 | -217.699 | -120.092 | -80.089 | 56.032 | 50.664 | 44.312 | 45.711 | 32.975 | 16.488 | 21.204 | 21.204 |
| Income Before Tax Ratio
| -24.367 | -0.068 | -1.319 | -0.455 | -4.065 | -0.024 | -0.494 | -4.191 | -4.457 | -0.241 | -0.483 | -0.652 | 0 | -0.372 | 0 | -1.208 | -0.394 | -0.352 | 0.212 | 0.173 | 0.162 | 0.213 | 0.182 | 0.182 | 0.242 | 0.242 |
| Income Tax Expense
| 2.962 | 4.663 | -2.548 | 4.546 | 5.578 | 5.376 | -0.306 | -4.833 | -3.837 | 24.712 | 2.059 | 0.073 | 0 | 0.658 | 0 | 2.318 | 8.614 | 1.826 | 7.336 | 8.798 | 8.224 | 8.42 | 5.968 | 2.984 | 3.498 | 3.498 |
| Net Income
| -110.652 | -7.988 | -332.243 | -96.012 | -508.033 | -9.765 | -71.289 | -71.197 | -129.56 | -59.872 | -120.982 | -79.132 | 0 | -56.739 | 0 | -215.381 | -111.478 | -81.915 | 48.696 | 41.866 | 36.088 | 37.291 | 27.007 | 13.504 | 17.706 | 17.706 |
| Net Income Ratio
| -10.493 | -0.029 | -4.336 | -0.353 | -2.922 | -0.012 | -0.362 | -3.626 | -3.144 | -0.919 | -0.429 | -0.575 | 0 | -0.373 | 0 | -1.195 | -0.366 | -0.36 | 0.184 | 0.143 | 0.132 | 0.174 | 0.149 | 0.149 | 0.202 | 0.202 |
| EPS
| -0.082 | -0.006 | -0.24 | -0.071 | -0.37 | -0.007 | -0.053 | -0.079 | -0.14 | -0.066 | -0.13 | -0.087 | 0 | -0.064 | 0 | -0.66 | -1.16 | -0.74 | 0.59 | 0.5 | 0.45 | 0.62 | 0.45 | 0.23 | 0.3 | 0.3 |
| EPS Diluted
| -0.082 | -0.006 | -0.24 | -0.071 | -0.37 | -0.007 | -0.053 | -0.079 | -0.14 | -0.066 | -0.13 | -0.087 | 0 | -0.064 | 0 | -0.66 | -1.16 | -0.74 | 0.59 | 0.5 | 0.45 | 0.62 | 0.45 | 0.23 | 0.3 | 0.3 |
| EBITDA
| -23.811 | -12.515 | -404.177 | -7.19 | 4.533 | 55.761 | -8.969 | -23.769 | -9.62 | -19.732 | -55.924 | -35.434 | 0 | -54.333 | 0 | -36.15 | -24.542 | 18.61 | 49.669 | 59.844 | 48.175 | 52.438 | 43.994 | 21.997 | 23.626 | 23.626 |
| EBITDA Ratio
| -2.258 | -0.046 | -5.275 | -0.026 | 0.026 | 0.066 | -0.046 | -1.21 | -0.233 | -0.303 | -0.198 | -0.258 | 0 | -0.357 | 0 | -0.201 | -0.081 | 0.082 | 0.188 | 0.204 | 0.177 | 0.245 | 0.243 | 0.243 | 0.269 | 0.269 |